CYP
Cynata Therapeutics Limited
About CYP
Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company focused on the development of therapies based on Cymerus, a proprietary therapeutic stem cell platform technology.
Buy Australian shares starting with CYP. Invest today with a CHESS-sponsored broker!
Market Capitalisation
$42M
Price-earnings ratio
-7.63
Dividend yield
0.00%
High today
$0.30
Low today
$0.29
Open price
$0.29
52-week high
$0.45
52-week low
$0.27
Announcements
CYP FAQs
How much is one share of Cynata Therapeutics Limited?
One share of Cynata Therapeutics Limited is valued at $0.30.
What is the ticker symbol for Cynata Therapeutics Limited?
The ticker symbol for Cynata Therapeutics Limited is CYP.
How do I buy CYP shares in Australia?
To buy CYP stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in CYP
What is the 52-week high for Cynata Therapeutics Limited stock?
The Cynata Therapeutics Limited 52-week high stock price is $0.45.
What is the 52-week low for Cynata Therapeutics Limited stock?
The Cynata Therapeutics Limited 52-week low stock price is $0.27.
What is the market capitalisation of Cynata Therapeutics Limited CYP?
As of 25/03/2023 Cynata Therapeutics Limited has a market cap of $42M.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.